CN1233477A - Medicine for treating hepatitis and liver fibrosis, and method for preparing same - Google Patents
Medicine for treating hepatitis and liver fibrosis, and method for preparing same Download PDFInfo
- Publication number
- CN1233477A CN1233477A CN 98101673 CN98101673A CN1233477A CN 1233477 A CN1233477 A CN 1233477A CN 98101673 CN98101673 CN 98101673 CN 98101673 A CN98101673 A CN 98101673A CN 1233477 A CN1233477 A CN 1233477A
- Authority
- CN
- China
- Prior art keywords
- radix
- extractum
- medicament
- root
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating hepatitis and cirrhosis and its prepn. method. It is composed of safflower 1-50(portion), red sage root 1-100, Chinese angelica root 1-50, bupleurum root 1-50, astragalus root 1-100, cyperus root 1-50, paeoniae alba root 1-50, herba artemisiae scopariae 1-50, licorice 1-50, isatis root 1-50, caulis spatholobi 1-100, fructus aurantil immaturus 1-50, cordyceps 1-30, phyllanthus 1-50, ganoderam 1-30. The invented medicine can be made into oral liquor, granules etc, and is good in therapeutic effect.
Description
The present invention relates to a kind of medicament and manufacture method thereof for the treatment of hepatitis and hepatic fibrosis, particularly a kind of Chinese medicine preparation and manufacture method thereof for the treatment of hepatitis and hepatic fibrosis.
Hepatitis is a kind of common infectious disease, though the Chinese patent medicine of some treatment hepatitis is arranged at present, curative effect is unsatisfactory, and therefore knock-on rate height, is necessary to provide a kind of treatment hepatitis eutherapeutic medicament.
The object of the invention provides a kind of medicament for the treatment of hepatitis and hepatic fibrosis, this medicine good effect, manufacture method uniqueness, suitable.
For achieving the above object, the present invention takes following design: the medicament of this treatment hepatitis and hepatic fibrosis mainly is made up of the raw material of following parts by weight: Flos Carthami 1-50 part, Radix Salviae Miltiorrhizae 1-100 part, Radix Angelicae Sinensis 1-50 part, Radix Bupleuri 1-50 part, Radix Astragali 1-100 part, Rhizoma Cyperi 1-50 part, Radix Paeoniae Alba 1-50 part, Artemisia anethoicles Mattf 1-50 part, Radix Glycyrrhizae 1-30 part, Radix Isatidis 1-50 part, Caulis Spatholobi 1-100 part, Fructus Aurantii Immaturus 1-50 part, Cordyceps 1-30, Herba Phyllanthi Urinariae 1-50, Ganoderma 1-30 part.
The method of treatment hepatitis and hepatic fibrosis medicament is that carry out the following step: Flos Carthami extracts volatile oil with the way of distillation according to above-mentioned each Chinese medicine proportioning; Radix Bupleuri, the Radix Astragali, Caulis Spatholobi, Herba Phyllanthi Urinariae, Rhizoma Cyperi, Artemisia anethoicles Mattf, Radix Isatidis, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, liquorice beverage are carried, and be condensed into extractum; Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae alcohol extraction also are condensed into extractum; Cordyceps, Ganoderma powder are broken into fine powder, fine powder are added in above-mentioned two kinds of extractum again, and vacuum drying, pulverizing spray into the volatile oil that is extracted by Flos Carthami with alcohol-soluble in the medicated powder.
15 flavor Chinese medicines have been adopted among the present invention, the Flos Carthami that blood circulation promoting and blood stasis dispelling is wherein arranged, the Chinese medicine that also have dispersing the stagnated live-QI to relieve the stagnation of QI, protects the liver, as Radix Bupleuri, Rhizoma Cyperi, the Radix Paeoniae Alba, Radix Salviae Miltiorrhizae, the Chinese medicine of antimicrobial antiphlogistic such as the Radix Astragali, Artemisia anethoicles Mattf, Radix Isatidis, Radix Glycyrrhizae, Cordyceps, the Chinese medicine of blood circulation promoting and enriching has Radix Angelicae Sinensis, Caulis Spatholobi, the Fructus Aurantii Immaturus of dispelling the stagnated QI intestinal stasis relieving etc.
In the above-mentioned Chinese medicine, adopted different extracts to form this prescription, the volatile oil that the employing steam distillation that has extracts; The extractum that the water extract of the employing routine that has, ethanol extract obtain through distilling under reduced pressure; Has plenty of the direct grind into powder of crude drug etc.
The invention will be further described below in conjunction with embodiment.
Embodiment 1:
Get the Flos Carthami of 30g,, extract volatile oil by the 62nd page of essential oil extraction method of mentioning of nineteen ninety-five version Chinese Pharmacopoeia.
Get Radix Salviae Miltiorrhizae 50g, Radix Angelicae Sinensis 50g, with 60% alcohol reflux of 6 times of doses, 2 hours time, after the filtration, in precipitation, add the ethanol (60%) of 4 times of precipitation weight again, extracted 1.5 hours, extracting solution refilters after leaving standstill, and the merging filtrate distilling under reduced pressure is the extractum of 1.25-1.3 to proportion.
Take by weighing Radix Bupleuri 30g, Radix Astragali 80g, Rhizoma Cyperi 60g, Radix Paeoniae Alba 50g, Artemisia anethoicles Mattf 8g, Radix Glycyrrhizae 20g, Radix Isatidis 80g, Herba Phyllanthi Urinariae 50g, Fructus Aurantii Immaturus 30g, Caulis Spatholobi 80g, above-mentioned Chinese medicine is for the first time with the water extraction of 12 times of medicine weight 2 hours, extract once again after the filtration, its water consumption is 10 times of medicine weight, 1.5 hours time, extracted twice liquid mixes, and it is 1.25-1.3 that distilling under reduced pressure is concentrated into proportion.
Cordyceps 50g, Ganoderma 50g are ground into fine powder, are added to and above-mentionedly extract respectively, concentrate in the extractum obtain through water, alcohol, vacuum drying, pulverizing (100 order), dry fine powder.
The above-mentioned volatile oil that is extracted by Flos Carthami is dissolved in ethanol, sprays into after the dissolving in the above-mentioned medicated powder, this medicated powder can be made oral liquid, granule, capsule and tablet etc.Wherein most convenient can be taken for incapsulating.
Advantage of the present invention: because prescription and technology uniqueness can be processed into different agent after making medicinal powder as required Type, this medicine good effect.
Claims (4)
1, a kind of medicament for the treatment of hepatitis and hepatic fibrosis, it is characterized in that: it mainly is made up of the raw material of following parts by weight: Flos Carthami 1-50 part, Radix Salviae Miltiorrhizae 1-100 part, Radix Angelicae Sinensis 1-50 part, Radix Bupleuri 1-50 part, Radix Astragali 1-100 part, Rhizoma Cyperi 1-50 part, Radix Paeoniae Alba 1-50 part, Artemisia anethoicles Mattf 1-50 part, Radix Glycyrrhizae 1-30 part, Radix Isatidis 1-50 part, Caulis Spatholobi 1-100 part, Fructus Aurantii Immaturus 1-50 part, Cordyceps 1-30, Herba Phyllanthi Urinariae 1-50, Ganoderma 1-30 part.
2, a kind of method of making described treatment hepatitis of claim 1 and hepatic fibrosis medicament, it is characterized in that: according to above-mentioned each Chinese medicine proportioning, carry out the following step: Flos Carthami extracts volatile oil with the way of distillation; Radix Bupleuri, the Radix Astragali, Caulis Spatholobi, Herba Phyllanthi Urinariae, Rhizoma Cyperi, Artemisia anethoicles Mattf, Radix Isatidis, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, liquorice beverage are carried, and be condensed into extractum; Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae alcohol extraction also are condensed into extractum; Cordyceps, Ganoderma powder are broken into fine powder, fine powder are added in above-mentioned two kinds of extractum again, and vacuum drying, pulverizing spray into the volatile oil that is extracted by Flos Carthami with alcohol-soluble in the medicated powder.
3, the manufacture method of the medicament of treatment hepatitis according to claim 2 and hepatic fibrosis, it is characterized in that: the number of times that described water is carried is twice, the water yield is respectively 12 times of doses, 10 times, extraction time is respectively after the quiet amount in 2 hours, 1.5 hours, water extract filters, and is evaporated to the extractum that proportion is 1.25-1.3.
4, according to the manufacture method of the medicament of claim 2 or 3 described treatment hepatitis and hepatic fibrosis, it is characterized in that: described alcohol extraction is adopted 60% alcohol reflux twice, the ethanol consumption is 6 times, 4 times of dose, extraction time was respectively 2 hours, 1.5 hours, after the quiet amount of alcohol extract is filtered, be evaporated to the extractum that proportion is 1.25-1.3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98101673A CN1098089C (en) | 1998-04-28 | 1998-04-28 | Medicine for treating hepatitis and liver fibrosis, and method for preparing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98101673A CN1098089C (en) | 1998-04-28 | 1998-04-28 | Medicine for treating hepatitis and liver fibrosis, and method for preparing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1233477A true CN1233477A (en) | 1999-11-03 |
| CN1098089C CN1098089C (en) | 2003-01-08 |
Family
ID=5216858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98101673A Expired - Lifetime CN1098089C (en) | 1998-04-28 | 1998-04-28 | Medicine for treating hepatitis and liver fibrosis, and method for preparing same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1098089C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004096252A1 (en) * | 2003-04-25 | 2004-11-11 | Primavera Biosciences, Inc. | Compositions and methods for weight loss |
| CN1321675C (en) * | 2000-11-24 | 2007-06-20 | 张志祥 | Liver-spleen capsule and its preparing process |
| CN101850035A (en) * | 2010-05-31 | 2010-10-06 | 拉萨市高原生物研究所 | Tibetan medicine-containing composition with anti-hepatic fibrosis function, preparation method thereof and application thereof in preparing anti-hepatic fibrosis medicines |
| CN101843704B (en) * | 2009-10-16 | 2011-08-31 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
| US8080264B2 (en) * | 2004-11-24 | 2011-12-20 | Himalaya Global Holdings Ltd. | Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof |
| CN102283956A (en) * | 2011-07-31 | 2011-12-21 | 李金伟 | Orally administered drug for treating chronic hepatitis |
| CN101199606B (en) * | 2006-12-14 | 2012-05-09 | 北京因科瑞斯生物制品研究所 | Medicament for treating liver disease |
| CN103142735A (en) * | 2013-03-09 | 2013-06-12 | 河北工程大学 | Traditional Chinese medicine oral liquid for treating duck virus hepatitis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1112834A (en) * | 1994-08-29 | 1995-12-06 | 郭约翰 | Method for preparing oral liquid for treating hepatitis B and its product |
| CN1061869C (en) * | 1996-09-10 | 2001-02-14 | 吴荫福 | Recovering powder for hepatitis B |
-
1998
- 1998-04-28 CN CN98101673A patent/CN1098089C/en not_active Expired - Lifetime
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1321675C (en) * | 2000-11-24 | 2007-06-20 | 张志祥 | Liver-spleen capsule and its preparing process |
| WO2004096252A1 (en) * | 2003-04-25 | 2004-11-11 | Primavera Biosciences, Inc. | Compositions and methods for weight loss |
| US8080264B2 (en) * | 2004-11-24 | 2011-12-20 | Himalaya Global Holdings Ltd. | Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof |
| CN101199606B (en) * | 2006-12-14 | 2012-05-09 | 北京因科瑞斯生物制品研究所 | Medicament for treating liver disease |
| CN101843704B (en) * | 2009-10-16 | 2011-08-31 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
| CN101850035A (en) * | 2010-05-31 | 2010-10-06 | 拉萨市高原生物研究所 | Tibetan medicine-containing composition with anti-hepatic fibrosis function, preparation method thereof and application thereof in preparing anti-hepatic fibrosis medicines |
| CN102283956A (en) * | 2011-07-31 | 2011-12-21 | 李金伟 | Orally administered drug for treating chronic hepatitis |
| CN102283956B (en) * | 2011-07-31 | 2013-01-16 | 郭清军 | Orally administered drug for treating chronic hepatitis |
| CN103142735A (en) * | 2013-03-09 | 2013-06-12 | 河北工程大学 | Traditional Chinese medicine oral liquid for treating duck virus hepatitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1098089C (en) | 2003-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101099763A (en) | Traditional Chinese medicine for treating headache | |
| CN100400094C (en) | Traditional Chinese medicine for treating hepatitis B and its preparing process | |
| CN1281716A (en) | Medicine for curing diabetic peripheral neuropathy | |
| CN1098089C (en) | Medicine for treating hepatitis and liver fibrosis, and method for preparing same | |
| CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
| CN1052413C (en) | Yinhuang Ganfu powder for curing hepatitis | |
| CN101062347A (en) | Chinese traditional medicine formula good for heart and brain | |
| CN100500183C (en) | Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN1823925A (en) | New preparation for treating constrained liver qi | |
| CN113476558A (en) | Traditional Chinese medicine composition for treating Parkinson's disease, traditional Chinese medicine preparation and traditional Chinese medicine product | |
| CN101264187A (en) | Medicinal composition for treating chronic prostatitis and prostatic hyperplasia | |
| CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN105395686A (en) | Folium artemisiae argyi-containing pharmaceutical preparation for treating vaginal bleeding and preparing method thereof | |
| CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
| CN101194959B (en) | Capsule for treating headache and method for preparing the same | |
| CN100475248C (en) | A medicine for treating metrorrhagia and preparation process thereof | |
| CN1589839A (en) | Stasis transforming pain relieving particle agent and its preparation method | |
| CN1814153A (en) | Medicine composition for preventing and treating breast cancer and preparing method | |
| CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
| CN114129684B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| CN1151813C (en) | Traditional Chinese medicine composition for curing insomnia | |
| CN108498696A (en) | It is a kind of to be used to treat chill pain in waist and lower extremities, the vina preparation process of muscles and bones numbness | |
| CN108524731B (en) | Traditional Chinese medicine composition for treating myasthenia gravis and preparation thereof | |
| CN101352496A (en) | Traditional Chinese medicine for treating hepatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING BEIDA WEIMING BIOLOGY ENGINEERING GROUP C Free format text: FORMER OWNER: XINDIYA MEDICINE NEW TECH. DEVELOPMENT CO., LTD., TIANJIN CITY Effective date: 20040211 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20040211 Address after: No. 100085 West Road, Beijing, Peking University biological city, 39 Patentee after: Beijing sinobioway Group Co., Ltd. Address before: 300240 Tianjin City, Hebei District Jianchang Road No. 54 days of life engineering company Patentee before: Xindiya Medicine New Tech. Development Co., Ltd., Tianjin City |